Upcoming events

Biodegradable polymer Everolimus-eluting SYNERGY stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

Sponsored by Boston Scientific

Elderly patients regularly receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of double antiplatelet therapy (DAPT). The aim of this study was to compare outcomes between these two types of stents with a short duration of DAPT in such patients. Study concluded that  BP-EES stent and a short duration of DAPT is better than BMS and a similar duration of DAPT with respect to the occurrence of all-cause mortality, myocardial infarction, stroke, and ischaemia-driven target lesion revascularisation.

Biodegradable polymer Everolimus-eluting SYNERGY stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

 
Download and read the full paper

Page published on December 2017

Sponsor

With an unrestricted educational grant from Boston Scientific

Disclaimer

This case report does not reflect the opinion of PCR or PCRonline, nor does it engage their responsibility.